SK BIOPHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88,400 KRW | -1.23% |
|
+0.91% | -11.95% |
| Jan. 30 | SK Biopharmaceuticals Swings to Profit in Q4 | MT |
| 2023 | SK Group Advances Net Zero Transition via Key Renewable Energy Deal | MT |
Evolution of the average Target Price on SK Biopharmaceuticals Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
a64643e63e8ddbaab84a3a5651c931f._tkVOvHrgEktn7WKLpJ4HS-WsgNBwPInUTNFNCsC-x8.zo5SDKW5wi18st7JftUzVn3zi0YZsMRjAWYBZWBBmVvPvSVv3L6yMRXd4A~ddaf6bcb3c7028797506caa2eab541a9
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
88,400
KRW
Average target price
106,133
KRW
Spread / Average Target
+20.06%
High Price Target
130,000
KRW
Spread / Highest target
+47.06%
Low Price Target
51,000
KRW
Spread / Lowest Target
-42.31%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
A-
EPS Revisions
- Stock Market
- Equities
- A326030 Stock
- Consensus SK Biopharmaceuticals Co., Ltd.